Medinotec (MDNC) Other Non-Current Assets (2024 - 2026)

Medinotec (MDNC) posted Other Non-Current Assets of $435.0 for Q2 2026, down 86.18% on a QoQ basis from $3148.0 in Q1 2026.

Medinotec (MDNC) Other Non-Current Assets (2024 - 2026) Analysis & Trends

Medinotec's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $435.0 for Q2 2026.

Quarterly Other Non-Current Assets changed N/A year-over-year to $435.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $435.0 (changed N/A YoY) and the FY2026 annual result came in at $3148.0, up 17.42% from the prior year.
Other Non-Current Assets was $435.0 for Q2 2026 at Medinotec, down from $3148.0 in the prior quarter.
Across five years, Other Non-Current Assets topped out at $3148.0 in Q1 2026 and bottomed at $435.0 in Q2 2026.
A 3-year average of $2219.0 and a median of $2646.5 in 2024 frame the typical range for Other Non-Current Assets.
Annual changes were most pronounced in 2025 — Other Non-Current Assets increased 2.64% — and 2026, when it rose 17.42%.
Medinotec's Other Non-Current Assets stood at $2612.0 in 2024, then rose by 2.64% to $2681.0 in 2025, then plunged by 83.77% to $435.0 in 2026.
Business Quant data shows MDNC's Other Non-Current Assets at $435.0 in Q2 2026, $3148.0 in Q1 2026, and $2681.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	3.17 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	4.15 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	2.05 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	738.90 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	285.90 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	828.89 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	2.25 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	164.00 Mn
10	Medinotec	58.78 Mn	58.19 Mn	1.31 Mn	435.00

Download Data